Elevated Cholesterol
12
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
8.3%
1 terminated out of 12 trials
90.0%
+3.5% vs benchmark
42%
5 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
The Medication Experience Study
A Pilot Study to Explore the Role of Gut Flora in Elevated Cholesterol
Impact of Alpine Dairy Products on Blood Lipid Levels
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C
A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol
Effects of a 4-week Raw, Plant-based Diet on Anthropometric and Cardiovascular Risk Factors
The Effect of Olive Leaf Extract Administration on Cardiovascular Health
Observational Study of Lyzme5 Impact on Cholesterol and Body Weight in Man